A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis
Clinical trial NCT02951182 · COMPLETED
Trial details
- NCT number
- NCT02951182
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-08-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.